Two new studies from the Boston University School of Public Health (BUSPH) shed light on the relationship between obesity and the use of prescription opioids in the United States.
A new Cochrane Special Collection, COVID-19: Effective options for quitting smoking during the pandemic, published today in the Cochrane Library.
Coughing fits, anxiety and paranoia are three of the most common adverse reactions to cannabis, according to a recent study by Washington State University researchers.
Researchers at Queen Mary University of London have shown that zebrafish can provide genetic clues to smoking, a complex human behaviour.
Those who consume alcohol and drive are often subjected to roadside stops, breathalyzer tests and stiff penalties if their blood alcohol content exceeds certain limits. Currently, no such test exists for cannabis intoxication, although the substance can impair driving. Now, scientists report a convenient saliva test for cannabis levels that might someday be used at roadside stops. The researchers will present their results today at the American Chemical Society Spring 2020 National Meeting & Exposition.
Doctors and nurses in emergency departments at four academic centers and four community hospitals in the Northeast reported a wide range of emotions triggered by patients, hospital resources and societal factors, according to a qualitative study led by a University of Massachusetts Amherst social psychologist.
A pair of new studies led by University of Alberta pediatricians indicate that parents are more reluctant to have opioids prescribed for their children than doctors are to prescribe them.
Unlocking the full potential of cannabis for agriculture and human health will require a co-ordinated scientific effort to assemble and map the cannabis genome, says a just-published international study led by University of Saskatchewan researchers.
The WSU research team found that rats with regular access to cannabis seek more of the substance and tend to show increased drug-seeking behavior when cannabis is absent.
UC's Health Geography and Disease Modeling Laboratory found that white males ages 30 to 39 were most at risk of fatal overdoses in Ohio. The study also identified 12 clusters in the state where overdose rates were highest.